Literature DB >> 30039320

Endoscopic submucosal dissection for papillary adenocarcinoma of the stomach: low curative resection rate but favorable long-term outcomes after curative resection.

Tae-Se Kim1, Byung-Hoon Min2, Kyoung-Mee Kim3, Jun Haeng Lee1, Poong-Lyul Rhee1, Jae J Kim1.   

Abstract

BACKGROUND: The previous studies demonstrated aggressive clinicopathologic features of papillary early gastric cancer (EGC). This raised concerns about the appropriateness of current Japanese guidelines that recommend the same endoscopic submucosal dissection (ESD) criteria for papillary EGC as for well-differentiated (WD) or moderately differentiated (MD) EGCs.
METHODS: This study included 4140 patients who underwent ESD for differentiated-type EGC (87 papillary EGCs and 4259 WD or MD EGCs). The clinicopathologic characteristics and short- and long-term outcomes of ESD for papillary EGC were reviewed and compared with those for WD or MD EGC.
RESULTS: Papillary EGCs were larger, and had higher lymphovascular and submucosal invasion rates than WD or MD EGCs. Lateral resection margin involvement and histological heterogeneity were found more frequently in papillary EGC than in WD or MD EGC. En bloc with R0 resection and curative resection rates of papillary EGC were 85.1 and 49.4%, respectively, and both were significantly lower than those of WD or MD EGC (93.0 and 82.2%). In mucosal cancers, curative resection rates of papillary EGC and WD or MD EGC were 72.5 and 93.7%, respectively. Among patients undergoing curative ESD for papillary EGC, no extra-gastric recurrences occurred during median 58 months of follow-up. Metachronous recurrence occurred in 5.2% of cases.
CONCLUSIONS: Given the favorable long-term outcomes after curative resection, ESD might be indicated for papillary EGC according to the current Japanese guidelines. As papillary EGC has considerable lymphovascular and submucosal invasion rates, careful histological examination is required to accurately determine whether curative ESD is achieved.

Entities:  

Keywords:  Endoscopic submucosal dissection; Gastric cancer; Papillary adenocarcinoma

Mesh:

Year:  2018        PMID: 30039320     DOI: 10.1007/s10120-018-0857-3

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  12 in total

1.  Long-term Outcomes of Additional Endoscopic Treatments for Patients with Positive Lateral Margins after Endoscopic Submucosal Dissection for Early Gastric Cancer.

Authors:  Tae-Se Kim; Byung-Hoon Min; Yang Won Min; Hyuk Lee; Poong-Lyul Rhee; Jae J Kim; Jun Haeng Lee
Journal:  Gut Liver       Date:  2021-09-01       Impact factor: 4.321

2.  Histological Differentiated/Undifferentiated Mixed Type Should Not Be Considered as a Non-Curative Factor of Endoscopic Resection for Patients With Early Gastric Cancer.

Authors:  Xiaolong Tang; Mengjun Zhang; Qingsi He; Guorui Sun; Chao Wang; Peng Gao; Hui Qu
Journal:  Front Oncol       Date:  2020-09-03       Impact factor: 6.244

3.  Endoscopic Submucosal Dissection of Papillary Gastric Adenocarcinoma; Systematic Review.

Authors:  Chang Seok Bang; Jae Jun Lee; Gwang Ho Baik
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

Review 4.  Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer.

Authors:  Chan Hyuk Park; Dong-Hoon Yang; Jong Wook Kim; Jie-Hyun Kim; Ji Hyun Kim; Yang Won Min; Si Hyung Lee; Jung Ho Bae; Hyunsoo Chung; Kee Don Choi; Jun Chul Park; Hyuk Lee; Min-Seob Kwak; Bun Kim; Hyun Jung Lee; Hye Seung Lee; Miyoung Choi; Dong-Ah Park; Jong Yeul Lee; Jeong-Sik Byeon; Chan Guk Park; Joo Young Cho; Soo Teik Lee; Hoon Jai Chun
Journal:  Clin Endosc       Date:  2020-03-30

5.  Comparison of clinicopathological features and long-term prognosis between mixed predominantly differentiated-type and pure differentiated-type early gastric cancer.

Authors:  Yutaka Okagawa; Tetsuya Sumiyoshi; Hitoshi Kondo; Yusuke Tomita; Takeshi Uozumi; Reiichi Iida; Hiroya Sakano; Kaho Tokuchi; Takashi Jin; Masahiro Yoshida; Akira Sakurada; Ryoji Fujii; Takeyoshi Minagawa; Kohtaro Morita; Kei Yane; Hideyuki Ihara; Michiaki Hirayama; Yumiko Oyamada; Shunichi Okushiba
Journal:  BMC Cancer       Date:  2021-03-06       Impact factor: 4.430

6.  Risk-Scoring System for Prediction of Non-Curative Endoscopic Submucosal Dissection Requiring Additional Gastrectomy in Patients with Early Gastric Cancer.

Authors:  Tae-Se Kim; Byung-Hoon Min; Kyoung-Mee Kim; Heejin Yoo; Kyunga Kim; Yang Won Min; Hyuk Lee; Poong-Lyul Rhee; Jae J Kim; Jun Haeng Lee
Journal:  J Gastric Cancer       Date:  2021-11-26       Impact factor: 3.720

7.  Favorable Long-Term Outcomes of Endoscopic Submucosal Dissection for Differentiated-Type-Predominant Early Gastric Cancer with Histological Heterogeneity.

Authors:  Tae-Se Kim; Hyeong Chan Shin; Byung-Hoon Min; Kyoung-Mee Kim; Yang Won Min; Hyuk Lee; Jun Haeng Lee; Poong-Lyul Rhee; Jae J Kim
Journal:  J Clin Med       Date:  2020-04-09       Impact factor: 4.241

Review 8.  Endoscopic submucosal dissection of papillary adenocarcinoma of stomach; protocol for a systematic review and meta-analysis.

Authors:  Chang Seok Bang; Jae Ho Choi; Jae Jun Lee; Gwang Ho Baik
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

9.  Clinicopathologic Features of Submucosal Papillary Gastric Cancer Differ from Those of Other Differentiated-Type Histologies.

Authors:  Seung Yong Shin; Jie-Hyun Kim; Myeong-Cherl Kook; Do Youn Park; Keun Won Ryu; Il Ju Choi; Sung Hoon Noh; Hyunki Kim; Yong Chan Lee
Journal:  Gut Liver       Date:  2021-01-15       Impact factor: 4.519

10.  Clinical practice guideline for endoscopic resection of early gastrointestinal cancer.

Authors:  Chan Hyuk Park; Dong-Hoon Yang; Jong Wook Kim; Jie-Hyun Kim; Ji Hyun Kim; Yang Won Min; Si Hyung Lee; Jung Ho Bae; Hyunsoo Chung; Kee Don Choi; Jun Chul Park; Hyuk Lee; Min-Seob Kwak; Bun Kim; Hyun Jung Lee; Hye Seung Lee; Miyoung Choi; Dong-Ah Park; Jong Yeul Lee; Jeong-Sik Byeon; Chan Guk Park; Joo Young Cho; Soo Teik Lee; Hoon Jai Chun
Journal:  Intest Res       Date:  2020-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.